250+ investors that invest in your industry and stage
Transportation
Gaming
Community
Proptech
FinTech
Biotech
Climate
Marketplace
Artificial intelligence
Energy
Hardware
Media (entertainment)
EdTech
Consumer
Health Care
Impact
Enterprise
Agriculture (agtech)
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Web3
Publishing
Clean Energy
Sporting Goods
Oil and Gas
B2B
Education
Organic Food
Big Data
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Video Games
Financial Services
Payments
Photography
Celebrity
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Franchise
Blockchain
Legal
Android
Social Impact
Mobile
Google
Construction
Sports
Local
eSports
Enterprise Software
Email
Wellness
Social Network
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Platforms
Biotechnology
Medical Device
Wine And Spirits
Automotive
Crowdfunding
Social
CleanTech
InsurTech
SaaS
Software
Film
Theatre
Life Science
Non Profit
Qatar
New Zealand
United States
South Korea
Germany
Australia
India
United Kingdom
Ireland
Canada
Africa
Asia
LATAM
Europe
Oceania
Middle East
China
South Africa
Singapore
Brazil
Japan
Indonesia
Sri Lanka
Vietnam
Spain
Saudi Arabia
Argentina
Armenia
Austria
Bangladesh
Bahrain
Belarus
Bulgaria
Belgium
Bermuda
Chile
Cameroon
Switzerland
Colombia
Belize
Costa Rica
Denmark
Ecuador
Algeria
Czech Republic
Georgia
Estonia
Egypt
Ghana
Hong Kong
Ethiopia
Gibraltar
Faroe Islands
Greece
Finland
Croatia
France
Hungary
Barbados
Kuwait
Italy
Jersey
Israel
Lebanon
Cambodia
Kenya
Cayman Islands
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Mali
Morocco
Norway
Malaysia
Mexico
Panama
Malta
Mauritius
Peru
Philippines
Nicaragua
Pakistan
Poland
Russian Federation
Romania
Sweden
Rwanda
Serbia
Seychelles
Turkey
Togo
Puerto Rico
Slovenia
Sierra Leone
San Marino
Senegal
Tunisia
Tanzania
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Thailand
Taiwan
Ukraine
Uruguay
Zimbabwe
Venezuela
Portugal
Azerbaijan
Bahamas
Guatemala
Iraq
Iceland
Namibia
Nigeria
United Arab Emirates
Honduras
Bolivia
Isle of Man
Luxembourg
Cyprus
Latvia
Oman
Angel investors
VC Funds
All investors
Download Find emails Save list

Top 30 Medical Device VC (Venture Capital) Funds in Australia in October 2023

A list of 30 VC (Venture Capital) funds that invest in Medical device startups based in Australia. We rank investors based on the number of investments they made in Medical device companies from Australia. We update this investor list every month.

Top 30 Medical Device VC (Venture Capital) Funds in Australia in October 2023

Investor Medical Device Australia investments
Brandon Capital Partners 7
Medical Research Commercialisation Fund (MRCF) 6
Melbourne Angels 4
Artesian VC 4
Global Health Investment Fund (GHIF) 2
Regal Funds Management 2
Uniseed Ventures 2
BridgeLane Capital 1
Transition Level Investments 1
Right Click Capital 1
Ramsay Health Care 1
VU Venture Partners 1
Powerhouse Ventures 1
Future of Healthcare Fund - Australian Unity 1
UniSA Ventures 1
Blackbird Ventures 1
CP Ventures 1
Terra Rossa Capital 1
Grand Challenges Canada 1
Victoria University of Wellington 1
Versant Ventures 1
Starfish Ventures 1
Playford Capital 1
OneVentures 1
Skip Capital 1
Sydney Angels 1
Breakthrough Victoria 1
South Australian Venture Capital Fund 1
HealthCare Ventures 1
Microsoft for Startups 1

Get 300+ niche investors in 2 minutes.

Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.

Find investors — It's Free!

Trusted by 21,000+ founders from:

Y Combinator Techstars Antler Pioneer On Deck
Investor list
Brandon Capital Partners
VC Fund · Melbourne, Victoria, Australia · 3 investments in the past 12 months

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom

Portfolio highlights

  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • Entact Bio — Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed tocreate enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.
  • NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
Show more investments...

Medical Research Commercialisation Fund (MRCF)
VC Fund · Melbourne, Victoria, Australia

Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom

Portfolio highlights

  • Glyscend — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
  • Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
  • Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Show more investments...

Melbourne Angels
VC Fund · Melbourne, Victoria, Australia

Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.

Show more...

Investment focus

  • Biotechnology, Information Technology, Manufacturing
  • Angel, Seed, Funding Round
  • Australia, United States, New Zealand

Portfolio highlights

  • Tayble — Spend more time enjoying your food and less time waiting.We hate waiting...For anything...And food and drinks are no exception!If your hobbies include:- Waiting in line - Calling out to a waiter - Watching the kettle boil - Calculating your split of the billPLEASE DO NOT DOWNLOAD THIS APP... YOU'LL HATE IT!But if you're likeus...And want your food and drinks ready exactly when you are...Or to leave a restaurant without worrying about your bill...Then step right up, this bad boy's for you!With Tayble, you’ll never have to flag down a waiter... EVER!Simply order from your "Tayble"Or before you even arrive...Leave the rest to us and the 1,000's of minions in the cloud that keep this all running!You’ll be left asking where has this been all my life, guaranteed!*(Definitely not a real guarantee)
  • Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
  • Apop Imaging — Apop Imaging develops and commercialises novel imaging, diagnostic and therapeutic tools to improve patient outcomes based on our proprietary calcitonin receptor antibody technology.
Show more investments...

Artesian VC
VC Fund · Melbourne, Victoria, Australia · 13 investments in the past 12 months

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

Show more...

Investment focus

  • Software, Artificial Intelligence, Information Technology
  • Seed, Series A, Pre-Seed
  • Australia, United States, Hong Kong

Portfolio highlights

  • ZoomAgri — ZOOMAGRI provides an assessment of agricultural commodities to all participants of Agri supply chain via AI, computer vision and IoT.
  • Supplynote — End-to-end supply chain management tool to track inventory, orders, payments and suppliers online
  • Navi Medical Technologies — Navi Medical Technologies is a medical device development company.
Show more investments...

Global Health Investment Fund (GHIF)
VC Fund · New York, New York, United States

The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Series B, Series C, Funding Round
  • United States, India, Austria

Portfolio highlights

  • Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
  • CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
  • Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Show more investments...

Regal Funds Management
VC Fund · Sydney, New South Wales, Australia · 3 investments in the past 12 months

Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.

Show more...

Investment focus

  • Software, Financial Services, FinTech
  • Funding Round, Series B, Convertible Note
  • Australia, United States, United Kingdom

Portfolio highlights

  • Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
  • SendFX — SendFX provides cross-border payment and remittance services to individuals and SMEs.
  • Send Payments — Send is a fast-growing fintech delivering embedded finance solutions to well-known brands.
Show more investments...

Uniseed Ventures
VC Fund · Brisbane, Queensland, Australia · 3 investments in the past 12 months

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

Show more...

Investment focus

  • Biotechnology, Manufacturing, Health Care
  • Series A, Seed, Funding Round
  • Australia, United States, United Kingdom

Portfolio highlights

  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Morse Micro — Smarter, farther, better. Meet the latest Wi-Fi, HaLow, 802.11ah. 10X FARTHER>1Km range, 100x area, 1000x volume 10X EFFICIENCYMulti-year on a single
  • Tiny Bright Things — Melbourne-based company Tiny Bright Things was cofounded in 2020 by long-time research collaborators Ray Dagastine and Chris Bolton. We invented Halo microscopy to transform the way researchers and manufacturers look at small or transparent things. This helps manufacturers in areas like agrichemicals and pharmaceuticals (where the size and shape ofpowders are critical) and researchers at every stage of discovery— particularly in nanotechnology (where samples are especially tiny) and life sciences (where samples are often also transparent).
Show more investments...

BridgeLane Capital
VC Fund · Sydney, New South Wales, Australia

The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme

Show more...

Investment focus

  • Software, Financial Services, Health Care
  • Seed, Series B, Funding Round
  • Australia, Germany

Portfolio highlights

  • Agerris — Agerris is a field robotics and AI start-up for the agriculture industry, based on technology created at the Australian Centre for Field Robotics, the University of Sydney, where they have been developing air and ground robotic solutions for the agriculture industry since 2005.
  • Sprout Stack
  • Evrima Technologies — Our clinical trial recruitment and management services put participants first. Trusted, timely clinical trial results are a good thing - for everybody.
Show more investments...

Transition Level Investments
VC Fund · Brisbane, Queensland, Australia

Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies. Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.

Show more...

Investment focus

  • SaaS, Artificial Intelligence, Software
  • Seed, Pre-Seed, Series A
  • Australia, United States

Portfolio highlights

  • Kapiche — Instant insights. No set up or coding. The Kapiche feedback analytics platform helps you ingest and analyze mountains of customer feedback in minutes.
  • FloodMapp — Enhance operational efficiency, lead time, situational awareness and decision making using FloodMapp rapid flood mapping software.
  • Chipper Cash — Join over 5 million people securely sending and receiving money with Chipper Cash. Great app to send and receive money across a number of countries, highly recommended as a money transfer alternative.
Show more investments...

Right Click Capital
VC Fund · Sydney, New South Wales, Australia · 1 investment in the past 12 months

Right Click Capital - Australian Venture Capital Firm

Show more...

Investment focus

  • Software, Artificial Intelligence, SaaS
  • Seed, Funding Round, Series A
  • Australia, Singapore, United States

Portfolio highlights

  • Cydarm — A case management platform that enables cybersecurity operations teams to collaborate, integrate, and respond with ease.
  • Reejig — At Reejig, we believe in zero wasted potential in people and in business – and that starts with harnessing the skills you have within your organisation. Our workforce intelligence platform provides 100% visibility of your people’s skills, potential, passions and experiences, creating a powerful central nervous system for all talent decisions.Powered by the world’s first independently audited Ethical Talent AI engine, Reejig generates the intelligence to instantly fill roles, track retention risks, mobilise talent to opportunities, pivot talent for reskilling and much more. Plus, we give you the power to ‘nudge’ people to new career opportunities, taking your engagement with internal and external talent to the next level. Put simply, we make workforce agility a reality.Reejig is trusted and used by some of the largest and most complex organisations including Woolworths, KPMG, NSW Government, John Holland, MYOB and UTS, and together we are creating a world where everyone can reach their full potential at work. It’s what we call zero-wasted potential in people and in business.
  • Nomad Atomics — At Nomad Atomics, we develop innovative quantum sensors to solve outstanding problems in mining, underground resources and navigation
Show more investments...

Ramsay Health Care
VC Fund · Sydney, New South Wales, Australia

Ramsay Health Care provides health care services to public and private patients. Its health care services comprise day surgery procedures and complex surgeries, as well as psychiatric care and rehabilitation services. It operates approximately 235 hospitals and day surgery facilities with approximately 25,000 beds in Australia, the United Kingdom,France, Indonesia, Malaysia, Maldives, and Italy. Paul Ramsay founded Ramsay Health Care in 1964. It has its headquarters in Sydney in Australia.

Show more...

Investment focus

  • Medical, Health Care, Medical Device
  • Series A
  • Australia

Portfolio highlights

  • Harrison.ai — Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients. The company leverages deep learning to solve the biggest challenges in healthcare and seeks to improve patient outcomes. It empowers physicians and healthcare providers with customized AI-enabled tools thatintegrate into existing clinical workflows which ultimately lead to improved patient outcomes.Harrison.ai uses the deskside DGX Station for experimentation, research, and development. The company uniquely combines exceptional deep learning expertise with clinical experience to develop and deploy healthcare AI solutions. Harrison.ai’s IVY deep learning model analyzes the full five-day video feed from an embryo scope, helping it surpass the performance of AI tools that provide insights based on still images.Harrison.ai's mission is to continuously innovate and commercialize more efficient and more affordable healthcare products and services to healthcare providers and patients.Harrison.ai was founded in 2018 and is headquartered in Barongarook, Victoria, Australia.
Show more investments...

VU Venture Partners
VC Fund · San Francisco, California, United States · 5 investments in the past 12 months

A multi-stage investment fund focused on Consumer, Enterprise, Fintech, Frontier, Healthcare, & PropTech

Show more...

Investment focus

  • Software, Health Care, Machine Learning
  • Seed, Funding Round, Series A
  • United States, Colombia, India

Portfolio highlights

  • Hadean — Hadean are a venture backed tech startup providing the most simple and secure platform for cloud native development. Intuitive and developer friendly, the Hadean Platform provides a friction free route to a cloud-native infrastructure. It lets you write applications once and deploy anywhere, taking care of setup, configuration, scaling, securityand more.Hadean have developed two flagship applications. Aether Engine provides distributed load balancing for agent-based simulations, while Muxer is a network model that utilises distributed edge networks. The result is spatial simulations of unparalleled size and complexity, where thousands of concurrent users can join and interact. Hadean have found traction in gaming, healthcare, virtual events and defence with industry leading companies such as Microsoft, Minecraft and CAE.
  • MarketForce — MarketForce connects Africa’s informal retail outlets and consumers directly to suppliers of consumer goods and financial services by digitizing orders, delivery, and payments with the aim of solving the last mile distribution challenge.
  • Dayta AI — SaaS Shopper Analytics - Cyclops presents you insightful data like shopper demographics, bahavioral metrics and many more. Drive more sales and traffic with AI now!
Show more investments...

Powerhouse Ventures
VC Fund · Oakland, California, United States · 4 investments in the past 12 months

Powerhouse Ventures backs entrepreneurs building the digital infrastructure for rapid decarbonization.

Show more...

Investment focus

  • Software, Energy, Solar
  • Seed, Series A, Pre-Seed
  • United States, Australia, United Kingdom

Portfolio highlights

  • Tyba — Tyba provides end-to-end modeling of standalone and hybrid storage projects from early-stage development through operations, giving your business the edge to build and operate the best projects faster and more profitably.
  • Axiom Cloud — Axiom Cloud Inc. uses AI to solve the biggest energy and maintenance problems plaguing the underserved commercial cooling/refrigeration industry ($120B/year in the US alone). Our first target customer segment is retail grocery. Customers pay an initial setup fee to install/configure the IoT platform onsite, along with recurring SaaSfees for one or more cloud-based software apps that run on the IoT platform.
  • Granular Energy — Granular Energy provides solutions for managing and trading clean energy. Our tools have been developed to support the recent emergence of 24/7 time-stamped energy certificates as well as traditional "annual" certificates.
Show more investments...

Future of Healthcare Fund - Australian Unity
VC Fund

A fund focused on delivering long term capital growth whilst increasing the wellbeing of Australians by investing in the future healthcare needs of Australians.

Show more...

Investment focus

  • Health Care, Medical Device
  • Series A
  • Australia

Portfolio highlights

  • Baymatob — Baymatob is an AI-guided solution to improve health outcomes for mothers and their babies.
Show more investments...

UniSA Ventures
VC Fund

UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).

Show more...

Investment focus

  • Software, Health Care, Biotechnology
  • Seed
  • Australia

Portfolio highlights

  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Framework — All-in-one productivity tool for teams & individuals.
Show more investments...

Blackbird Ventures
VC Fund · Sydney, New South Wales, Australia · 27 investments in the past 12 months

Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.

Show more...

Investment focus

  • Software, SaaS, Information Technology
  • Seed, Series A, Series B
  • Australia, United States, New Zealand

Portfolio highlights

  • Marqo — A tensor-based search and analytics engine that seamlessly integrates with your applications, websites, and workflows.
  • BioticsAI — Advancing Fetal Ultrasound Screenings Using AI
  • Kiki — Kiki is a subletting startup that matches listers with people looking to rent for up to six months.
Show more investments...

CP Ventures
VC Fund · Sydney, New South Wales, Australia · 1 investment in the past 12 months

CP Ventures is a VC fund that invests internationally in early stage, highly scalable, breakthrough technology companies driven by the 4IR

Show more...

Investment focus

  • Software, Artificial Intelligence, Machine Learning
  • Seed, Pre-Seed, Series A
  • Australia, United States, India

Portfolio highlights

  • Anility — Embed financial health insights within your application using our world leading API service
  • Ahura AI — Ahura AI, an EdTech startup using artificial intelligence to create personalized learning tools that replicate a 1-to-1 learning experience
  • Ensuredit — ENSUREDIT enables and empowers end customers and Insurance Intermediaries with AI-based product platforms for transformational customer experience.
Show more investments...

Terra Rossa Capital
VC Fund · Adelaide, South Australia, Australia

Terra Rossa Capital Pty Ltd operates as a venture capital fund. The Company invests in life science companies. Terra Rossa Capital serves clients in Australia.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Series A, Series B
  • Australia

Portfolio highlights

  • Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable point‐of‐care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
Show more investments...

Grand Challenges Canada
VC Fund · Toronto, Ontario, Canada

Grand Challenges Canada is dedicated to supporting Bold Ideas with Big Impact® in global health. They are funded by the Government of Canada and they fund innovators in low- and middle-income countries (LMICs) and Canada. The bold ideas they support integrate science and technology, social and business innovation – they call this IntegratedInnovation®. They focus on bringing successful innovation to scale, catalyzing sustainability and impact. They have a determined focus on results, and on saving and improving lives.Grand Challenges Canada works closely with Canada’s International Development Research Centre (IDRC), the Canadian Institutes of Health Research (CIHR) and Global Affairs Canada to catalyze scale, sustainability and impact. Grand Challenges Canada takes an evidence-based approach to development innovation to save and improve lives in LMICs. They are a platform for development innovation in Maternal, Newborn and Child Health (MNCH) through their Saving Lives at Birth, Saving Brains and MNCH Stars in Global Health programs. They are also focused on helping the poorest and most vulnerable populations, for example those who suffer from mental illness.Since their launch in 2010, Grand Challenges Canada has supported a pipeline of over 700 projects in more than 80 countries. Their investments are producing results: Thousands of lives have been saved and over two hundred and eighty thousand lives have been improved, thus far. By 2030, these innovations have the potential to save hundreds of thousands of lives and improve millions of lives.

Show more...

Investment focus

  • Health Care, Medical Device, Biotechnology
  • Grant, Seed, Debt Financing
  • Canada, United States, Australia

Portfolio highlights

  • OmniVis — OmniVis is a technology company creating handheld devices to rapidly detect dangerous pathogens - saving food and saving lives.
  • Nivi, Inc. — Nivi is the best digital health chatbot built for whatsapp and rooted in behavioral science. Nivi enables users to take charge of their own health and works with private and public agencies to driver better public health outcomes.
  • Sensoreal — Sensoreal Inc. is a diagnostic device and service provider company. The company is developing a variety of biosensors, which can perform one-step immunoassays in low-cost, accurate and quantifiable manners. Sensoreal was founded in 2014, and is headquartered in Montreal, Canada.
Show more investments...

Victoria University of Wellington
VC Fund · Wellington, Wellington, New Zealand

A tradition of fostering strong global links in teaching and research and programmes of national significance and international quality.

Show more...

Portfolio highlights

  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Show more investments...

Versant Ventures
VC Fund · Menlo Park, California, United States · 7 investments in the past 12 months

Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • United States, Switzerland, Canada

Portfolio highlights

  • Kate Therapeutics — Kate Therapeutics is a patient-focused biotechnology company developing AAV-based gene therapies to treat genetically defined muscle and heart diseases.
  • Nexo Therapeutics — Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies.
  • Tentarix Biotherapeutics — Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology. The company develops a protein engineering platform designed for multispecific therapies.
Show more investments...

Starfish Ventures
VC Fund · Melbourne, Victoria, Australia

Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.

Show more...

Investment focus

  • Software, Enterprise Software, Information Technology
  • Series A, Series B, Funding Round
  • United States, Australia, Philippines

Portfolio highlights

  • Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
  • DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,136,169 freelance designers compete to create amazing designs for your business. Start Today!
  • Marani — Marani Health is developing a prenatal care platform which includes a wearable, textile-based product to measure key vital statistics of women and their developing fetus, for use during pregnancy, labor & delivery. The products utilize Artificial Intelligence to better assess health & wellness during pregnancy, labor & delivery. Maraniis collaborating with key partners including The Mayo Clinic.
Show more investments...

Playford Capital
VC Fund · Adelaide, South Australia, Australia

Playford Capital is a venture capital arm of South Australian Government Financing Authority specializing in investments in start-ups, early venture, mid venture, late venture stages, and growth capital.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Series A, Series B
  • Australia

Portfolio highlights

  • Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable point‐of‐care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
Show more investments...

OneVentures
VC Fund · Sydney, New South Wales, Australia · 4 investments in the past 12 months

OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.

Show more...

Investment focus

  • Software, Health Care, Information Technology
  • Series A, Debt Financing, Funding Round
  • Australia, United States, Israel

Portfolio highlights

  • Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
  • BiVACOR — BiVACOR is a privately held company founded in 2008. Their staff includes world-class engineers, medical specialists, and business executives, who are diligently working to advance this ground-breaking technology. Together, they have established a strong collaborative network that extends both nationally and internationally. Their worldheadquarters is located in Houston, Texas, USA, and their international office is in Brisbane, Australia.
  • ImmVirX — ImmVirX is an Australian company founded in 2019 with a mission to improve outcomes for patients with cancer types in which immunotherapy treatments have limited effect.
Show more investments...

Skip Capital
VC Fund · Sydney, New South Wales, Australia · 1 investment in the past 12 months

Skip Capital is a private investment fund investing in technology and infrastructure

Show more...

Investment focus

  • Software, SaaS, Artificial Intelligence
  • Series A, Seed, Series B
  • Australia, Canada, United States

Portfolio highlights

  • Neara — Neara electric utility software is a physics-enabled platform that builds 3D interactive models of critical infrastructure networks and assets. Request a demo.
  • Human — Human aims to assist medical professionals and patients to make more statistics selections.
  • Morse Micro — Smarter, farther, better. Meet the latest Wi-Fi, HaLow, 802.11ah. 10X FARTHER>1Km range, 100x area, 1000x volume 10X EFFICIENCYMulti-year on a single
Show more investments...

Sydney Angels
VC Fund · Sydney, New South Wales, Australia

Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.

Show more...

Investment focus

  • Software, SaaS, Apps
  • Seed, Funding Round, Angel
  • Australia, United States

Portfolio highlights

  • Kapiche — Instant insights. No set up or coding. The Kapiche feedback analytics platform helps you ingest and analyze mountains of customer feedback in minutes.
  • Remi AI — A.I-Powered Demand Forecasting, Supply Chain AI, & Price Optimisation | Remi AI
  • Trendspek — Trendspek is the drone data solution asset managers use to make empowered decisions and ensure absolute asset knowledge. Conduct complete visual inspections from any web browser. Extract detailed insights without a site visit. Use powerful tools to analyse the structure and build a complete picture of asset condition. Enhance predictive maintenanceby closely monitoring trends. View different models side by side to observe important differences. Refine your understanding of an ever-changing asset.
Show more investments...

Breakthrough Victoria
VC Fund · Melbourne, Victoria, Australia · 5 investments in the past 12 months

Independent investment company managing the $2 billion Breakthrough Victoria Fund to make Victoria a global innovation leader.

Show more...

Investment focus

  • Quantum Computing, Software, Training
  • Series A, Seed, Series B
  • Australia, United States

Portfolio highlights

  • FLAIM Systems — FLAIM Systems is a virtual reality platform that develops, produces and supports the next step in skills training for emergency services.
  • Quantum Brilliance — Quantum Brilliance builds room temperature quantum computers powered by synthetic diamond, enabling applications in everyday computing, including edge and massively parrellelized computing.
  • Navi Medical Technologies — Navi Medical Technologies is a medical device development company.
Show more investments...

South Australian Venture Capital Fund
VC Fund · Adelaide, South Australia, Australia · 1 investment in the past 12 months

South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.

Show more...

Investment focus

  • Health Care, Biotechnology, SaaS
  • Funding Round, Series A, Series B
  • Australia

Portfolio highlights

  • Lumary — Simplify Your Care Management Optimise Your Organisation Create Better Wellbeing
  • BiomeBank — BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial ecology.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Show more investments...

HealthCare Ventures
VC Fund · Cambridge, Massachusetts, United States

HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.

Show more...

Investment focus

  • Biotechnology, Health Care, Pharmaceutical
  • Series B, Series A, Series C
  • United States, Australia, United Kingdom

Portfolio highlights

  • Colorescience — Know Better Skin with Colorescience. From mineral sunscreen to clinical skincare products, achieve a clear, even complexion and protect your skin from the damaging effects of the sun and environmental aggressors such as pollution. Shop Now!
  • Leap Therapeutics — Leap Therapeutics, Inc., a clinical-stage biopharmaceutical company, is engaged in acquiring and developing novel therapeutics. The company focus is to identify translational-stage molecules in the areas of cell signaling and immuno-oncology.
  • Proteostasis Therapeutics — Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, aredesigned to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.
Show more investments...

Microsoft for Startups
VC Fund · Redmond, Washington, United States · 11 investments in the past 12 months

Microsoft for Startups is a global program designed to help startups scale with free access to Azure cloud and a streamlined path into selling alongside Microsoft and our vast partner ecosystem.

Show more...

Investment focus

  • Software, Information Technology, SaaS
  • Seed, Funding Round, Grant
  • United States, India, Canada

Portfolio highlights

  • UniPay — UniPay is an eCommerce platform for infrastructure and industry-lacking regions that offers 5 products that enable trust, promote transparency, and enforce accountability.
  • NotJustEvent — NotJustEvent stands at the forefront of innovation as a comprehensive event platform transforming the event planning and management landscape, utilizing advanced technologies and offering a versatile suite of services. We seamlessly link event organizers, vendors, performers, and attendees within our dynamic ecosystem. Our platform elevates theevent planning process by providing an array of high-quality event-related services, such as venue rentals, catering, ticketing, decorations, and more.
  • Emission Sentri — Drive emission management and reduction with insights
Show more investments...
Investors by industry
Investors by country
VC (Venture Capital) Funds in Australia by industry

Close your round

Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.

Find investors — It's Free!

Join 21,000+ founders from:

Y Combinator Techstars Antler Pioneer On Deck